Scholars Central

Review articlePublished 27 Mar 2023

Using tissue culture and Biotechnology in manufacturing Coronary Stents to reduce late complications

Authors: Johny Cena

Translational Biomedicine

Volume 14 · Issue 3 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The use of tissue culture and biotechnology in manufacturing coronary stents has shown potential in reducing late complications. The development of biodegradable stents that can be absorbed into the body has minimized the risks associated with long-term complications such as restenosis and thrombosis. Tissue engineering techniques have also enabled the production of stents that mimic the structure and function of the natural vessel, promoting tissue regeneration and reducing inflammation. The incorporation of drug-eluting systems in stents has improved the efficacy of drug delivery to the targeted site, leading to reduced complications. These innovative technologies hold great promise for improving the outcomes of patients with coronary artery disease.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Translational Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTranslational Biomedicine
  • SubjectBiochemistry & Biotechnology
  • SubjectCardiology
  • SubjectEngineering
  • BylineArticles whose byline prints “Johny Cena”